Tumor-infiltrating CD4+ T cells and CD8+ T cells from mice given low-dose TSA treatment had an increased frequency of TNF-α and IFN-γ producers compared with vehicle treatment group (Fig. 2g). This evidence concerns the gene CD8A and neoplasm.